Found: 2
Select item for more details and to access through your institution.
Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac406
- By:
- Publication type:
- Article
Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 4, p. 1, doi. 10.1093/ofid/ofac053
- By:
- Publication type:
- Article